238 related articles for article (PubMed ID: 6542154)
21. [Fibrinolytic and thrombolytic properties of a plasminogen activator isolated from the culture broth of calf kidney cells].
Egorov BB; Andreenko GV; Liaginskiĭ AV; Stelingovskií KV; Podorol'skaia LV
Farmakol Toksikol; 1983; 46(4):54-6. PubMed ID: 6684592
[TBL] [Abstract][Full Text] [Related]
22. A comparative ex vivo study of plasminogen activators and proteases for fibrinolytic activity and side effects in rabbits.
Janik BA; Papaioannou SE
Thromb Haemost; 1977 Feb; 37(1):154-61. PubMed ID: 576512
[TBL] [Abstract][Full Text] [Related]
23. Fibrinolytic agents: mechanisms of activity and pharmacology.
Lijnen HR; Collen D
Thromb Haemost; 1995 Jul; 74(1):387-90. PubMed ID: 8578491
[TBL] [Abstract][Full Text] [Related]
24. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
25. Synergism of thrombolytic agents: investigational procedures and clinical potential.
Collen D
Circulation; 1988 Apr; 77(4):731-5. PubMed ID: 3127075
[No Abstract] [Full Text] [Related]
26. [New thrombolytic agents].
Okada K
Rinsho Byori; 1992 Mar; Suppl 92():115-30. PubMed ID: 1583770
[No Abstract] [Full Text] [Related]
27. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
Korninger C; Matsuo O; Suy R; Stassen JM; Collen D
J Clin Invest; 1982 Mar; 69(3):573-80. PubMed ID: 7199539
[TBL] [Abstract][Full Text] [Related]
28. [Extrinsic plasminogen activator: molecular properties and potential value as a new thrombolytic agent].
Collen D
Verh K Acad Geneeskd Belg; 1982; 44(5-6):295-305. PubMed ID: 6223460
[No Abstract] [Full Text] [Related]
29. Characterization and antithrombotic action of tissue plasminogen activator.
Bergqvist D; Nilsson IM; Pandolfi M
Experientia; 1984 Jan; 40(1):67-8. PubMed ID: 6229416
[TBL] [Abstract][Full Text] [Related]
30. New strategies in the development of thrombolytic agents.
Lijnen HR; Collen D
Curr Stud Hematol Blood Transfus; 1991; (58):69-72. PubMed ID: 1954777
[No Abstract] [Full Text] [Related]
31. [The vasomotor effects of the enzymes of the fibrinolytic system in rats].
Sergeev IIu; Bashkov GV
Fiziol Zh Im I M Sechenova; 1996; 82(10-11):52-7. PubMed ID: 9162395
[TBL] [Abstract][Full Text] [Related]
32. Nonradical excited oxygen species induce selective thrombolysis in vivo.
Stief TW
Thromb Res; 1991 May; 62(3):147-63. PubMed ID: 1716380
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology of thrombolytic agents. Implications for therapy of coronary artery thrombosis.
Marder VJ
Circulation; 1983 Aug; 68(2 Pt 2):I2-5. PubMed ID: 6683134
[TBL] [Abstract][Full Text] [Related]
34. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
Thorsen S; Astrup T
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
[No Abstract] [Full Text] [Related]
35. Stachybotrydial selectively enhances fibrin binding and activation of Glu-plasminogen.
Sasaoka M; Wada Y; Hasumi K
J Antibiot (Tokyo); 2007 Nov; 60(11):674-81. PubMed ID: 18057696
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Collen D; Lijnen HR
Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
[TBL] [Abstract][Full Text] [Related]
37. The role of the fibrinolytic system in corneal angiogenesis.
Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
[TBL] [Abstract][Full Text] [Related]
38. Biological properties of recombinant and of natural pro-urokinase.
Gurewich V; Pannell R
Thromb Haemost; 1985 Aug; 54(2):558-9. PubMed ID: 3936220
[No Abstract] [Full Text] [Related]
39. [Role of single chain pro-UK on the initiation and regulation of fibrinolysis].
Arimura H; Kasai S; Nishida M; Suyama T
Rinsho Byori; 1989 Apr; Spec No 81():107-17. PubMed ID: 2502639
[No Abstract] [Full Text] [Related]
40. Isolation of SMTP-3, 4, 5 and -6, novel analogs of staplabin, and their effects on plasminogen activation and fibrinolysis.
Hasumi K; Ohyama S; Kohyama T; Ohsaki Y; Takayasu R; Endo A
J Antibiot (Tokyo); 1998 Dec; 51(12):1059-68. PubMed ID: 10048563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
